Deerfield Management Company, L.P. (Series C) Lemaitre Vascular Inc Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 4,169 shares of LMAT stock, worth $366,913. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,169Holding current value
$366,913% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding LMAT
# of Institutions
298Shares Held
21.5MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.48MShares$306 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.6MShares$141 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC1.57MShares$139 Million2.22% of portfolio
-
Copeland Capital Management, LLC940KShares$82.8 Million1.75% of portfolio
-
Geneva Capital Management LLC915KShares$80.6 Million1.3% of portfolio
About LEMAITRE VASCULAR INC
- Ticker LMAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 21,962,900
- Market Cap $1.93B
- Description
- LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...